A kind of preparation method of salbutamol hydrochloride

By successfully preparing high-purity levol hydrochloride from 5-(2-bromoacetyl)-2-hydroxybenzaldehyde starting material, through aldehyde reduction and propylene protection, the yield in the prior art was solved. Low, expensive catalysts and pollution problems have achieved the preparation of levol hydrochloride suitable for industrial production.

CN114409552BActive Publication Date: 2024-11-05GUANGZHOU BOJI BIOMEDICAL SCI PARK CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202210096615.3
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-01-26
Publication Date
2024-11-05
Estimated Expiration
2042-01-26

AI Technical Summary

Technical Problem

The existing synthesis method of levol hydrochloride has low yields, the catalyst is expensive, heavy metal contamination, and the need for column chromatography purification is not conducive to large-scale industrial production.

Method used

5-(2-bromoacetyl)-2-hydroxybenzaldehyde is used as the starting material, and the deprotection is obtained through aldehyde reduction, propylene protection, carbonyl asymmetric reduction, epoxidation, chiral resolution and purification, and finally deprotection is obtained. L-albutamol hydrochloride, the whole process is carried out under mild conditions, avoiding the use of expensive or contaminated reagents, and does not require column chromatography purification, reaching a purity of more than 99%.

Benefits of technology

It has achieved a preparation method for levol hydrochloride with high yield, low cost, environmental protection, simple operation and low equipment requirements, which is suitable for large-scale industrial production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN114409552B_ABST
    Figure CN114409552B_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of chemical synthesis, and in particular to a method for preparing salbutamol hydrochloride. The method uses 5-(2-bromoacetyl)-2-hydroxybenzaldehyde as starting material, and sequentially undergoes aldehyde reduction, propylidene protection, carbonyl asymmetric reduction, epoxidation, amine generation, chiral separation and purification, and deprotection salt formation to prepare salbutamol hydrochloride. The whole method reacts under relatively mild conditions, without expensive or easily contaminated reagents, and can reach a purity of more than 99% without combining column chromatography purification; and the synthetic route is simple to operate, has low equipment requirements, and has a good yield, which is very suitable for industrial large-scale production.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of chemical synthesis and more specifically relates to a preparation method of levosalbutamol hydrochloride. Background Art

[0002] Salbutamol is a selective β2 receptor agonist that can effectively inhibit the release of allergenic substances such as histamine and prevent bronchospasm. It is suitable for bronchial asthma, asthmatic bronchitis, bronchospasm, emphysema and other diseases. It is the first choice for relieving acute asthma attacks and has long been one of the world's top ten best-selling single drugs. Levosalbutamol hydrochloride is a single optical isomer of salbutamol. Its efficacy is 80 times that of dexasalbutamol, with fewer side effects and further improved efficacy. Levosalbutamol hydrochloride only needs 1 / 4 of the dose of the racemate to produce the same therapeutic effect. At 1 / 2 dose, its effect is better than the racemate. Therefore, levosalbutamol is expected to replace salbutamol and become the first choice for relieving acute asthma attacks.

[0003] At present, the synthesis routes of salbutamol hydrochloride are mainly divided into two types:

[0004] One method is to use a chiral reagent to separate and purify the racemic salbutamol. For example, Chen Yang et al. (Chen Yang, Liu Xiangkui, Zhang Xiaomin, et al. Preparation of levosalbutamol hydrochloride [J]. Chinese Journal of Pharmaceutical Industry, Vol. 37, No. 6, 2006, pp. 376-378, ISTIC PKU CSCD CA BP, 2006.) disclosed a synthetic route of levosalbutamol hydrochloride:

[0005]

[0006] However, this method has a low raw material utilization rate, and the total yield after purification is only 28.5%, which is not suitable for large-scale industrial production.

[0007] The other method is to construct a chiral center so that the ratio of salbutamol hydrochloride is much greater than that of dextrosalbutamol hydrochloride, and then purify the product to improve the yield. For example, Cheng Qingfang et al. disclosed an asymmetric synthesis method of (R)-salbutamol hydrochloride (Cheng Qingfang, Wang Qifa, Xu Xingyou, Ye Yanbin, Zhang Hui. Asymmetric Synthesis of (R)-salbutamol Hydrochloride [J]. Organic Chemistry, 2007 (12): 1558-1561.), and the specific synthesis route is as follows:

[0008]

[0009] This method uses a chiral borneol-based β-diketone iron complex as a catalyst to catalyze the asymmetric epoxidation reaction of styrene compounds, thereby achieving high enantioselective epoxidation of styrene compounds and ultimately achieving the purpose of synthesizing salbutamol. However, this route requires the use of expensive iron complexes and post-treatment requires column chromatography, which is not conducive to industrial scale-up.

[0010] Similarly, Zhou Shiyang et al. disclosed a chemical asymmetric synthesis method for (R)-salbutamol, which uses 1-(4-hydroxy-5-hydroxymethylphenyl)-aminoethyl ketone as a raw material, undergoes a coupling reaction catalyzed by CuI, and then uses (-)-Ipc2BCl as a reducing agent to enantioselectively reduce the carbonyl group to finally generate (R)-salbutamol (Zhou Shiyang, Chen Ling. Chemical Asymmetric Synthesis of (R)-Salbutamol [J]. Journal of Shenyang University (Natural Science Edition), 2015, 27(06): 442-445. DOI: 10.16103 / j.cnki.21-1583 / n.2015.06.004.); however, this route requires a large amount of copper catalyst and causes heavy metal pollution to the environment, which is not conducive to environmental protection. Summary of the invention

[0011] The technical problem to be solved by the invention is to overcome the defects and shortcomings of the existing method for synthesizing levosalbutamol hydrochloride, such as low yield, expensive catalyst and heavy metal pollution, and the need for column chromatography purification which is not conducive to industrial scale-up, and to provide a method for preparing levosalbutamol hydrochloride with low cost, high yield, mild conditions, green and environmental protection, simple operation, low equipment requirements and suitable for industrial large-scale production.

[0012] The above-mentioned purpose of the present invention is achieved through the following technical solutions:

[0013] A preparation method of levosalbutamol hydrochloride is synthesized by the following route:

[0014]

[0015] The specific steps include:

[0016] S1. Compound A (5-(2-bromoacetyl)-2-hydroxybenzaldehyde) is reacted in an organic solvent at 10-20° C. under the reducing conditions of sodium triacetoxyborohydride to obtain compound B (5-(2-bromoacetyl)-2-hydroxybenzyl alcohol);

[0017] S2. Compound B (5-(2-bromoacetyl)-2-hydroxybenzyl alcohol) obtained in step S1 is subjected to cyclization with 2,2-dimethoxypropane in the presence of a catalyst, and reacted in an organic solvent at 20 to 30° C. to obtain compound C (6-bromoacetyl-2,2-dimethyl-4H-benzo[1,3]dioxin);

[0018] S3. In the presence of a borane complex and a chiral ligand, the compound C (6-bromoacetyl-2,2-dimethyl-4H-benzo[1,3]dioxin) obtained in step S2 is reduced in an organic solvent at 0 to 10° C. to obtain a chiral intermediate compound D (6-(2-bromo-1-(S)-ethanol)-2,2-dimethyl-4H-benzo[1,3]dioxin);

[0019] S4. Compound D (6-(2-bromo-1-(S)-ethanol)-2,2-dimethyl-4H-benzo[1,3]dioxin) obtained in step S3 is reacted in an organic solvent at 20-30° C. in the presence of potassium carbonate to obtain epoxide intermediate compound E (6-(2-(S)-ethylene oxide)-2,2-dimethyl-4H-benzo[1,3]dioxin);

[0020] S5. Compound E obtained in step S4 is subjected to a ring-opening reaction with tert-butylamine in an organic solvent at 45 to 55° C. to reverse the configuration, and chiral separation is performed using a resolving agent D-(+)-dibenzoyltartaric acid (D-DBTA) in an organic solvent at 45 to 55° C. to obtain D-(+)-dibenzoyltartaric acid salt of compound F;

[0021] S6. Deprotecting the D-(+)-dibenzoyl tartaric acid salt of compound F obtained in step S5 in an organic solvent at 15-25° C. under the action of hydrogen chloride, and purifying to obtain the compound.

[0022] Furthermore, in step S1, the organic solvent is selected from one or more of dichloromethane, methanol, tetrahydrofuran, and acetonitrile. Preferably, the organic solvent is tetrahydrofuran.

[0023] Preferably, in step S1, the mass volume ratio of the compound A to the organic solvent is 1:(5-10) g / ml.

[0024] Preferably, in step S1, the molar ratio of compound A to sodium triacetoxyborohydride is 1:(1-2).

[0025] Furthermore, in step S2, the catalyst is p-toluenesulfonic acid, glacial acetic acid or sulfuric acid. Preferably, the catalyst is p-toluenesulfonic acid.

[0026] Preferably, in step S2, the molar ratio of compound B to catalyst is 1:(0.01-0.05).

[0027] Preferably, in step S2, the organic solvent is dichloromethane, tetrahydrofuran, toluene or 1,4-dioxane; more preferably, the organic solvent is dichloromethane.

[0028] Preferably, in step S2, the mass volume ratio of the compound B to the organic solvent is 1:(10-15).

[0029] Furthermore, in step S3, the borane complex is N,N-diethylaniline.

[0030] Preferably, in step S3, the molar ratio of compound C to the borane complex is (1-2):1.

[0031] Preferably, in step S3, the chiral ligand is (1R, 2S)-(+)-cis-1-amino-2-indanol.

[0032] Preferably, in step S3, the organic solvent is tetrahydrofuran.

[0033] Furthermore, in step S4, the molar ratio of compound D to potassium carbonate is 1:(1-3).

[0034] Preferably, in step S4, the organic solvent is methanol, ethanol or isopropanol. Preferably, the organic solvent is methanol.

[0035] Preferably, in step S4, the mass volume ratio of the compound D to the organic solvent is 1:(5-10) g / ml.

[0036] Furthermore, in step S5, the molar ratio of the compound E to tert-butylamine is 1:(4-6).

[0037] Preferably, in step S5, the organic solvent for the ring-opening reaction is methanol, ethanol or isopropanol; preferably, the organic solvent for the ring-opening reaction is ethanol.

[0038] Preferably, in step S5, the mass volume ratio of the compound D in the ring-opening reaction to the organic solvent is 1:(5-10) ml / g.

[0039] Furthermore, in step S5, the molar ratio of compound E to the resolving agent is 1:(0.4-0.6).

[0040] Preferably, in step S5, the organic solvent for chiral resolution is a mixed solution of methanol and isopropanol in a volume ratio of 1:10.

[0041] Preferably, step S5 also includes a pulping purification step, and the pulping purification solvent is a mixed solution of methanol and water, wherein the mass volume ratio of compound F to methanol is 1:10, and the mass volume ratio to water is 1:(0.5~2.0); the pulping temperature is 50°C, and the crystallization temperature is 20±5°C.

[0042] Furthermore, in step S6, the organic solvent is a mixed solvent obtained by mixing any one of ethyl acetate, methyl tert-butyl ether, isopropyl ether, and dichloromethane with methanol in a volume ratio of 10:1.

[0043] Preferably, in step S6, the mass volume ratio of D-(+)-dibenzoyltartrate of compound F to the mixed solvent is 1:(10-15) g / ml.

[0044] Preferably, in step S6, the refining is recrystallization refining; the recrystallization solvent is a mixed solution of isopropanol and water, the mass volume ratio of the crude compound G to isopropanol is 1:12 g / ml, and the mass volume ratio to water is 1:(0.5-2.0), the recrystallization crystallization temperature is 20-30°C, and after the crystallization is completed, it is kept warm at -5-5°C for 2h.

[0045] The present invention has the following beneficial effects:

[0046] The invention uses 5-(2-bromoacetyl)-2-hydroxybenzaldehyde (compound A) as a starting material, and sequentially undergoes aldehyde reduction, propylidene protection, carbonyl asymmetric reduction, epoxidation, amine substitution, chiral separation and purification, and deprotection salt formation to prepare levosalbutamol hydrochloride. The entire method is carried out under relatively mild conditions, does not require expensive or easily contaminated reagents, and can achieve a purity of more than 99% without combining column chromatography purification; and the synthetic route is simple to operate, has low equipment requirements, and has a good yield, and is very suitable for industrial large-scale production. BRIEF DESCRIPTION OF THE DRAWINGS

[0047] Figure 1 The present invention provides a liquid chromatogram of the levosalbutamol hydrochloride prepared by the present invention. DETAILED DESCRIPTION

[0048] The present invention is further described below in conjunction with the accompanying drawings and specific examples, but the examples do not limit the present invention in any form. Unless otherwise specified, the reagents, methods and equipment used in the present invention are conventional reagents, methods and equipment in the art.

[0049] Unless otherwise specified, the reagents and materials used in the following examples are commercially available.

[0050] Specifically, the preparation method of levosalbutamol hydrochloride of the present invention is synthesized according to the following route:

[0051] Example 1 Synthesis of Compound B (5-(2-bromoacetyl)-2-hydroxybenzyl alcohol)

[0052]

[0053] (1) Weigh 200.53 g of compound A (5-(2-bromoacetyl)-2-hydroxybenzaldehyde), add 2.0 L of tetrahydrofuran, stir and dissolve, and cool to 15° C.; weigh 263.51 g of sodium triacetoxyborohydride, add it to the reaction system in batches, control the temperature at 20±5° C., add the materials for 120 min, and react at 20° C. for 60 min;

[0054] (2) HPLC and TLC monitoring until the reaction is complete, add 2.0 L of purified water, quench at room temperature for 60 min, concentrate below 40°C to remove most of the tetrahydrofuran, add 1.6 L of ethyl acetate, stir and extract, let stand to separate, extract the aqueous phase with 0.4 L of ethyl acetate once, combine the organic phases, wash once with 1.0 L of purified water; add an appropriate amount of anhydrous sodium sulfate to remove water;

[0055] (3) Filter, wash the filter residue with a small amount of ethyl acetate, collect the filtrate, and concentrate under reduced pressure below 40° C. to remove most of the solvent. When a large amount of solid is precipitated, add 600 mL of a mixed solution of dichloromethane and 600 mL of n-heptane, and slurry at room temperature for 1 hour; filter, rinse the filter cake with a small amount of n-heptane, and vacuum dry at 50° C. for 8 hours to obtain 160.45 g of a light khaki solid, which is compound B (5-(2-bromoacetyl)-2-hydroxybenzyl alcohol), with a molar yield of 79.36% and a purity of 92.80%;

[0056] (4) Compound B 1 HNMR(500MHz, DMSO)7.88-7.87(d,1H)7.69-7.67(m,1H)6.73-6.71(d,1H)4.92(s,2H)4.49(s,2H).

[0057] Example 2 Synthesis of Compound C (6-bromoacetyl-2,2-dimethyl-4H-benzo[1,3]dioxin)

[0058]

[0059] (1) Weigh 150.06 g of compound B (5-(2-bromoacetyl)-2-hydroxybenzyl alcohol), add 1.5 L of dichloromethane, stir and disperse at room temperature, add 1.16 g of p-toluenesulfonic acid monohydrate; weigh 128.87 g of 2,2-dimethoxypropane, add dropwise to the reaction system, and react at room temperature for 2 h;

[0060] (2) HPLC and TLC monitoring until the reaction is complete, add 0.75 L of purified water, adjust the pH to 7-8 with saturated potassium bicarbonate solution, let stand for stratification, collect the lower organic phase, and wash the organic phase once with 0.75 L of purified water; add anhydrous sodium sulfate to the organic phase to remove water;

[0061] (3) Filter, wash the filter residue with a small amount of dichloromethane, and concentrate under reduced pressure to obtain 174.01 g of oily substance, which is compound C (6-bromoacetyl-2,2-dimethyl-4H-benzo[1,3]dioxin), which is directly used in the next step reaction without calculating the yield;

[0062] (4) Compound C 1 HNMR(500MHz, DMSO)7.83-7.81(m,1H)7.79(s,1H)6.93-6.91(d,1H)5.06(s,2H)4.89(s,2H)1.50(s,6H).

[0063] Example 3 Synthesis of Compound D (6-(2-bromo-1-(S)-ethanol)-2,2-dimethyl-4H-benzo[1,3]dioxin)

[0064]

[0065] (1) Weigh 9.21 g of (1R, 2S)-(+)-cis-1-amino-2-indanol, add 1.5 L of anhydrous tetrahydrofuran, replace nitrogen, cool to 5±5°C, slowly dropwise add 150.31 g of N,N-diethylaniline borane (DEANB) under nitrogen protection, and keep warm at 5±5°C for 30 min after the addition is complete;

[0066] (2) Compound C (6-bromoacetyl-2,2-dimethyl-4H-benzo[1,3]dioxin) was added to 1.5 L of anhydrous tetrahydrofuran and stirred to dissolve. Under nitrogen protection, the compound was added dropwise to the reaction system of (1) above. The addition time was 180 min and the temperature was maintained at 5±5°C. After the addition was complete, the reaction was continued for 30 min.

[0067] (3) HPLC and TLC monitoring until compound C (6-bromoacetyl-2,2-dimethyl-4H-benzo[1,3]dioxin) is completely consumed and intermediate compound D is generated;

[0068] (4) Add 200 ml of acetone at 5±5°C to quench the borane. After the addition is complete, slowly raise the temperature to room temperature and react overnight.

[0069] (5) Concentrate to remove most of the tetrahydrofuran, add 1.5L of ethyl acetate and 0.75L of purified water, stir and extract, collect the upper organic phase, and wash the organic phase once with 0.5L of purified water; combine the aqueous phases, and back-extract once with 0.35L of ethyl acetate; combine the organic phases, and wash once with 0.5L of saturated sodium chloride solution; add anhydrous sodium sulfate, and dry to remove water;

[0070] (6) Filter, wash the residue with a small amount of ethyl acetate, collect the filtrate, concentrate under reduced pressure, remove most of the ethyl acetate, add 1.2 L of n-heptane for 1 h, filter, and dry under vacuum at 50 ° C to obtain 134.12 g of a white solid; the molar yield (calculated based on compound B) is 75.99%, and the HPLC purity is 95.74%;

[0071] (7) Compound D 1 HNMR(500MHz, DMSO)7.18-7.16(dd,1H)7.09(s,1H)6.76-6.73(d,1H)4.80(s,2H)4.71-4.68(m,1H)3.62-3.50(m,2H)1.45(s,1H).

[0072] Example 4 Synthesis of Compound F (6-((R)-hydroxy-2-(tert-butylamino)-ethyl)-2,2-dimethyl-4H-benzo[1,3]dioxin)

[0073]

[0074] (1) Weigh 130.88 g of compound D, add 1.3 L of methanol, stir to dissolve, add 125.87 g of potassium carbonate, and react at room temperature for 1 h;

[0075] (2) The reaction was controlled by TLC until it was complete, the solid was removed by filtration, the solid was washed with ethyl acetate, and the filtrates were combined and collected; the filtrate was concentrated below 40°C to remove most of the solvent, 1.3L ethyl acetate and 0.7L purified water were added, stirred for extraction, and allowed to stand for stratification; the organic phase was collected, the aqueous phase was extracted once with 0.4L ethyl acetate, the organic phases were combined, and washed once with 0.7L saturated sodium chloride solution; anhydrous sodium sulfate was added, and the water was dried to remove water;

[0076] (3) Filter, wash with a small amount of ethyl acetate, collect the filtrate; concentrate under reduced pressure below 40° C. to remove the solvent to obtain a yellow oily substance, which is a crude product of compound E;

[0077] (4) The obtained oil was dissolved in 1.0 L of anhydrous ethanol, 132.65 g of tert-butylamine was added dropwise, and the reaction was carried out at 50 ± 5 °C for 16 h;

[0078] (5) The reaction was controlled by TLC until it was complete; most of the solvent was removed by concentration, 1.0 L of ethyl acetate and 1.0 L of purified water were added, the mixture was stirred for extraction, and the mixture was allowed to stand for stratification; the organic phase was collected, and the aqueous phase was extracted once with 0.3 L of ethyl acetate; the organic phases were combined, and the mixture was washed once with 0.5 L of purified water and once with 0.5 L of saturated sodium chloride solution, and anhydrous sodium sulfate was added, and the mixture was dried to remove water;

[0079] (6) Filter, wash the filter residue with a small amount of ethyl acetate, and collect the filtrate; the filtrate is concentrated under reduced pressure to obtain a yellow viscous substance, which is the crude product of compound F; the yield is not calculated and it is directly used in the next step reaction.

[0080] Example 5 Synthesis and purification of D-(+)-dibenzoyl tartrate salt of compound F (6-((R)-hydroxy-2-(tert-butylamino)-ethyl)-2,2-dimethyl-4H-benzo[1,3]dioxin)

[0081] (1) The crude compound F obtained in Example 4 was dissolved in a mixed solvent of 0.8 L methanol and 0.8 L isopropanol, and the temperature was raised to 50±5° C. for later use;

[0082] (2) Weigh 68.13 g of D-(+)-dibenzoyltartaric acid (D-DBTA), dissolve it in a mixed solvent of 0.4 L methanol and 0.4 L isopropanol, and add it dropwise to the reaction system after the reaction temperature rises to 50±5°C. After the addition is complete, keep the temperature for 2 h, and a large amount of solid precipitates;

[0083] (3) Cool to room temperature and stir at room temperature for 2 h;

[0084] (4) Filter and dry under vacuum at 50°C to obtain 93.88 g of a white solid, which is a crude compound F;

[0085] (5) Add the obtained crude compound F into a reaction bottle, add 940 mL of methanol and 47 mL of purified water, raise the temperature to 50±5°C and keep it for 2 h;

[0086] (6) Cool down to room temperature and keep warm for 2 h;

[0087] (7) Filter, wash with a small amount of cold methanol, and dry in vacuo at 50°C for 5 h to obtain 80.38 g of a white solid; molar yield: 40.12% (calculated based on compound D); chiral purity: 99.74%;

[0088] (8) Compound E 1 HNMR(500MHz,DMSO)7.13-7.11(dd,1H)7.04-7.03(d,1H)6.73-6.71(d,1H)4.80(s,2H)4.45-4.43(m,1H)2.61-2.54(m,2H)1.45(s,6H)1.02(s,9H);

[0089] (9) Compound F 1HNMR(500MHz,DMSO)7.99-7.97(d,4H)7.64-7.60(m,2H)7.51-7.48(m,4H)7.12-7.10(m,2H)7.01(s,2H) 5.65(s,2H)4.77(s,4H)4.72-4.69(m,2H)2.90-2.87(m,4H)2.72-2.67(m,2H)1.45(s,12H)1.14(s,18H).

[0090] Example 6 Synthesis and Refining of Levosalbutamol Acid

[0091]

[0092] (1) Weigh 40.26 g of chiral intermediate F (6-((R)-hydroxy-2-(tert-butylamino)-ethyl)-2,2-dimethyl-4H-benzo[1,3]dioxin) D-(+)-dibenzoyl tartrate, add 800 mL of methyl tert-butyl ether and 80 mL of methanol, replace nitrogen, and cool to 20±5°C;

[0093] (2) Under nitrogen protection, add 45.7 mL of 4 M ethyl acetate and react at 20 °C for 5 h;

[0094] (3) HPLC and TLC monitoring until the reaction is complete, filtering, washing the filter cake with methyl tert-butyl ether 2 to 3 times, and transferring to a forced air drying oven at 50°C to dry for 8 h;

[0095] (4) 24.32 g of off-white solid was obtained, which was crude salbutamol hydrochloride;

[0096] (5) The crude product was dissolved in 292 mL of isopropanol and 20 mL of purified water under reflux temperature, filtered while hot, cooled to room temperature for crystallization for 2 h, and then kept at 0 °C for 2 h;

[0097] (6) Filter and wash with a small amount of cold isopropanol; transfer to a 60° C. vacuum drying oven and dry for 10 h to obtain 13.19 g of white solid, which is the finished product compound G of levosalbutamol hydrochloride, with a molar yield of 52.42%, HPLC purity of 98.66%, and chiral purity of 99.81%.

[0098] (7) Compound G 1HNMR(500MHz,DMSO)9.41-9.39(m,1H)9.25(s,1H)8.48-8.44(m,1H)7.34(s,1H)7.09-7.07(d,1H)6.80 -6.77(m,1H)5.97-5.96(d,1H)5.00(s,1H)4.89-4.86(m,1H)4.48(s,2H)2.96-2.82(m,2H)1.31(s,9H).

[0099] (8) The liquid phase spectrum of the related substances of the obtained product levosalbutamol hydrochloride can be found in Figure 1 .

[0100] As can be seen from the figure, the salbutamol hydrochloride (retention time 16.222 min) prepared by the present invention has a higher purity.

[0101] The above embodiments are preferred implementation modes of the present invention, but the implementation modes of the present invention are not limited to the above embodiments. Any other changes, modifications, substitutions, combinations, and simplifications that do not deviate from the spirit and principles of the present invention should be equivalent replacement methods and are included in the protection scope of the present invention.

Claims

1. A method for preparing salbutamol hydrochloride, characterized in that: It is synthesized by the following route: The specific steps include:

1. Synthesis of Compound B 5-(2-bromoacetyl)-2-hydroxybenzyl alcohol: (1) Weigh 200.53 g of compound A 5-(2-bromoacetyl)-2-hydroxybenzaldehyde, add 2.0 L of tetrahydrofuran, stir and dissolve, and cool to 15° C.; weigh 263.51 g of sodium triacetoxyborohydride, add it to the reaction system in batches, control the temperature at 20±5° C., add the materials for 120 min, and react at 20° C. for 60 min; (2) HPLC and TLC monitoring until the reaction is complete, add 2.0 L of purified water, quench at room temperature for 60 min, concentrate below 40°C to remove most of the tetrahydrofuran, add 1.6 L of ethyl acetate, stir and extract, let stand to separate, extract the aqueous phase with 0.4 L of ethyl acetate once, combine the organic phases, wash once with 1.0 L of purified water; add an appropriate amount of anhydrous sodium sulfate to remove water; (3) Filter, wash the filter residue with a small amount of ethyl acetate, collect the filtrate, and concentrate under reduced pressure below 40° C. to remove most of the solvent. When a large amount of solid is precipitated, add 600 mL of a mixed solution of dichloromethane and 600 mL of n-heptane, and slurry at room temperature for 1 hour; filter, rinse the filter cake with a small amount of n-heptane, and vacuum dry at 50° C. for 8 hours to obtain 160.45 g of a light khaki solid, which is compound B 5-(2-bromoacetyl)-2-hydroxybenzyl alcohol, with a molar yield of 79.36% and a purity of 92.80%; 2. Synthesis of Compound C 6-bromoacetyl-2,2-dimethyl-4H-benzo[1,3]dioxin: (1) Weigh 150.06 g of compound B 5-(2-bromoacetyl)-2-hydroxybenzyl alcohol, add 1.5 L of dichloromethane, stir and disperse at room temperature, add 1.16 g of p-toluenesulfonic acid monohydrate; weigh 128.87 g of 2,2-dimethoxypropane, add dropwise to the reaction system, and react at room temperature for 2 h; (2) HPLC and TLC monitoring until the reaction is complete, add 0.75 L of purified water, adjust the pH to 7-8 with saturated potassium bicarbonate solution, let stand for stratification, collect the lower organic phase, and wash the organic phase once with 0.75 L of purified water; add anhydrous sodium sulfate to the organic phase to remove water; (3) Filter, wash the filter residue with a small amount of dichloromethane, and concentrate under reduced pressure to obtain 174.01 g of an oily substance, which is compound C 6-bromoacetyl-2,2-dimethyl-4H-benzo[1,3]dioxin; 3. Synthesis of Compound D 6-(2-bromo-1-(S)-ethanol)-2,2-dimethyl-4H-benzo[1,3]dioxin: (1) Weigh 9.21 g of (1R, 2S)-(+)-cis-1-amino-2-indanol, add 1.5 L of anhydrous tetrahydrofuran, replace nitrogen, cool to 5±5°C, slowly dropwise add 150.31 g of N,N-diethylaniline borane (DEANB) under nitrogen protection, and keep warm at 5±5°C for 30 min after the addition is complete; (2) Compound C 6-bromoacetyl-2,2-dimethyl-4H-benzo[1,3]dioxin was added to 1.5 L of anhydrous tetrahydrofuran and stirred to dissolve. The mixture was then added dropwise to the reaction system of (1) under nitrogen protection for 180 min. The temperature was maintained at 5±5° C. After the addition was complete, the reaction was continued for 30 min. (3) HPLC and TLC monitoring until compound C 6-bromoacetyl-2,2-dimethyl-4H-benzo[1,3]dioxin is completely consumed and intermediate compound D is generated; (4) Add 200 ml of acetone at 5±5°C to quench the borane. After the addition is complete, slowly raise the temperature to room temperature and react overnight. (5) Concentrate to remove most of the tetrahydrofuran, add 1.5L of ethyl acetate and 0.75L of purified water, stir and extract, collect the upper organic phase, and wash the organic phase once with 0.5L of purified water; combine the aqueous phases, and back-extract once with 0.35L of ethyl acetate; combine the organic phases, and wash once with 0.5L of saturated sodium chloride solution; add anhydrous sodium sulfate, and dry to remove water; (6) Filter, wash the filter residue with a small amount of ethyl acetate, collect the filtrate, concentrate under reduced pressure, remove most of the ethyl acetate, add 1.2 L of n-heptane to slurry for 1 h, filter, and dry under vacuum at 50 ° C to obtain 134.12 g of a white solid; the molar yield calculated based on compound B is 75.99%, and the HPLC purity is 95.74%; 4. Synthesis of Compound F 6-((R)-Hydroxy-2-(tert-butylamino)-ethyl)-2,2-dimethyl-4H-benzo[1,3]dioxin: (1) Weigh 130.88 g of compound D 6-(2-bromo-1-(S)-ethanol)-2,2-dimethyl-4H-benzo[1,3]dioxin, add 1.3 L of methanol and stir to dissolve, add 125.87 g of potassium carbonate, and react at room temperature for 1 h; (2) The reaction was controlled by TLC until it was complete, the solid was removed by filtration, the solid was washed with ethyl acetate, and the filtrates were combined and collected; the filtrate was concentrated below 40°C to remove most of the solvent, 1.3L ethyl acetate and 0.7L purified water were added, stirred for extraction, and allowed to stand for stratification; the organic phase was collected, the aqueous phase was extracted once with 0.4L ethyl acetate, the organic phases were combined, and washed once with 0.7L saturated sodium chloride solution; anhydrous sodium sulfate was added, and the water was dried to remove water; (3) Filter, wash with a small amount of ethyl acetate, collect the filtrate; concentrate under reduced pressure below 40° C. to remove the solvent to obtain a yellow oily substance, which is a crude product of compound E; (4) The obtained oily substance E was dissolved in 1.0 L of anhydrous ethanol, 132.65 g of tert-butylamine was added dropwise, and the reaction was carried out at 50±5°C for 16 h; (5) The reaction was controlled by TLC until it was complete; most of the solvent was removed by concentration, 1.0 L of ethyl acetate and 1.0 L of purified water were added, the mixture was stirred for extraction, and the mixture was allowed to stand for stratification; the organic phase was collected, and the aqueous phase was extracted once with 0.3 L of ethyl acetate; the organic phases were combined, and the mixture was washed once with 0.5 L of purified water and once with 0.5 L of saturated sodium chloride solution, and anhydrous sodium sulfate was added, and the mixture was dried to remove water; (6) Filter, wash the filter residue with a small amount of ethyl acetate, and collect the filtrate; the filtrate is concentrated under reduced pressure to obtain a yellow viscous substance, which is the crude product of compound F; the yield is not calculated and it is directly used in the next step reaction; V. Synthesis and purification of compound F D-(+)-dibenzoyl tartrate salt of 6-((R)-hydroxy-2-(tert-butylamino)-ethyl)-2,2-dimethyl-4H-benzo[1,3]dioxin: (1) The crude compound F obtained in step 4 was dissolved in a mixed solvent of 0.8 L methanol and 0.8 L isopropanol, and the temperature was raised to 50±5° C. for later use; (2) Weigh 68.13 g of D-(+)-dibenzoyltartaric acid (D-DBTA), dissolve it in a mixed solvent of 0.4 L methanol and 0.4 L isopropanol, and add it dropwise to the reaction system after the reaction temperature rises to 50±5°C. After the addition is complete, keep the temperature for 2 h, and a large amount of solid precipitates; (3) Cool to room temperature and stir at room temperature for 2 h; (4) Filter and dry under vacuum at 50°C to obtain 93.88 g of a white solid, which is a crude product of compound F; (5) Add the obtained crude compound F into a reaction bottle, add 940 mL of methanol and 47 mL of purified water, raise the temperature to 50±5°C and keep it for 2 h; (6) Cool down to room temperature and keep warm for 2 h; (7) Filter, wash with a small amount of cold methanol, and dry in vacuo at 50°C for 5 h to obtain 80.38 g of a white solid; the molar yield calculated based on compound D is 40.12%; chiral purity: 99.74%; VI. Synthesis and purification of compound G levosalbutamol hydrochloride: (1) Weigh 40.26 g of chiral intermediate F 6-((R)-hydroxy-2-(tert-butylamino)-ethyl)-2,2-dimethyl-4H-benzo[1,3]dioxin D-(+)-dibenzoyltartrate, add 800 mL of methyl tert-butyl ether and 80 mL of methanol, replace nitrogen, and cool to 20±5°C; (2) Under nitrogen protection, add 45.7 mL of 4 M ethyl acetate and react at 20 °C for 5 h; (3) HPLC and TLC monitoring until the reaction is complete, filtering, washing the filter cake with methyl tert-butyl ether 2 to 3 times, and transferring to a forced air drying oven at 50°C to dry for 8 h; (4) 24.32 g of off-white solid was obtained, which was crude salbutamol hydrochloride; (5) The crude product was dissolved in 292 mL of isopropanol and 20 mL of purified water under reflux temperature, filtered while hot, cooled to room temperature for crystallization for 2 h, and then kept at 0 °C for 2 h; (6) Filter and wash with a small amount of cold isopropanol; transfer to a 60° C. vacuum drying oven and dry for 10 h to obtain 13.19 g of a white solid, which is the finished product compound G of salbutamol hydrochloride, with a molar yield of 52.42%; HPLC purity of 98.66%; and chiral purity of 99.81%.